Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
29 June, 2017 21:29 IST
Alembic Pharma gets USFDA's tentative nod for Vilazodone HCl tablets
Source: IRIS | 19 Apr, 2017, 11.14AM
Comments  |  Post Comment

Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Vilazodone Hydrochloride Tablets, 10mg, 20mg and 40mg.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Viibryd Tablets, 10 mg, 20mg and 40mg, of Forest Labs LLC. Vilazodone Hydrochloride Tablets are indicated for the treatment of Major Depressive Disorder (MDD). Alembic is currently in litigation with Forest Labs LLC in District Court of Delaware and has stipulated to stay the case in view of the ongoing settlement discussions.

Vilazodone Hydrochloride Tablets have an estimated market size of USD 340 million for twelve months ending December 2016 according to IMS.

Alembic now has a total of 54 ANDA approvals (47 final approvals and 7 tentative approvals) from the USFDA.

Shares of the company gained Rs 12, or 1.97%, to trade at Rs 621.95. The total volume of shares traded was 7,783 at the BSE (11.05 a.m., Wednesday).



Alembic Pharmaceuticals Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
ICICI Bank led consortium of banks concludes largest asset resolution - 29-Jun-2017 16:14
BHEL inks technology collaboration agreement with Kawasaki Heavy Ind - 29-Jun-2017 16:03
Madhucon Projects secures orders worth Rs 2.16 bn - 29-Jun-2017 14:50
GST will be India's 'Economic Freedom': Anil Ambani - 29-Jun-2017 14:47
Government to divest 5% stake in Rashtriya Chemicals & Fertilisers - 29-Jun-2017 11:49
Crude oil price of Indian basket rises marginally - 29-Jun-2017 11:44
Zydus Cadila receives USFDA approval for ADHD drug - 29-Jun-2017 11:15
Time Technoplast completes trial production composite cylinders - 29-Jun-2017 11:10
Rajesh Exports bags new export order worth Rs 7.74 bn - 29-Jun-2017 10:59
MEP Infra bags LoA worth Rs 3.25 bn from MSRDC - 29-Jun-2017 10:38
Mindtree board approves Rs 2.70 bn buyback - 29-Jun-2017 09:50
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer